S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
OTCMKTS:CDMGF

Icade - CDMGF Stock Forecast, Price & News

$48.93
0.00 (0.00%)
(As of 08/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$48.93
$48.93
50-Day Range
$48.00
$58.16
52-Week Range
$48.00
$79.30
Volume
N/A
Average Volume
377 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.14
CDMGF stock logo

About Icade (OTCMKTS:CDMGF) Stock

As an investor and a developer, Icade is an integrated real estate player that designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is closely involved with stakeholders and users in the citieslocal authorities and communities, companies and employees, institutions and associations. As an office and healthcare property investor (portfolio value of 11.6bn as of 06/30/2020 on a proportionate consolidation basis) and as a property developer (2019 economic revenues of nearly 1bn), Icade has been able to reinvent the real estate business and foster the emergence of tomorrow's greener, smarter and more responsible cities. Icade is a significant player in the Greater Paris area and major French cities. Icade is listed on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC). Its leading shareholder is the Caisse des dépôts Group.

Receive CDMGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Icade and its competitors with MarketBeat's FREE daily newsletter.

CDMGF Stock News Headlines

See More Headlines
Receive CDMGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Icade and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
REIT - Diversified
Sub-Industry
N/A
Current Symbol
OTCMKTS:CDMGF
CIK
N/A
Fax
N/A
Employees
1,178
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$62.62
High Stock Price Forecast
$68.50
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+29.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Olivier Wigniolle (Age 59)
    MD & CEO
    Comp: $490.56k
  • Ms. Victoire Aubry (Age 56)
    Head of Fin., IT & Work Environment
  • Ms. Sophie Duval
    Head of Consolidation & Accounting
  • Jean d'Aillières
    Head of Investor Relations
  • Ms. Anne-Sophie Lanaute
    Head of Financial Communication & Investor Relations
  • Mr. Jérôme Lucchini (Age 55)
    Gen. Sec. and Head of Governance, Legal Insurance & Department
  • Mr. Laurent Poinsard (Age 56)
    Head of Audit, Risk, Compliance & Internal Control
  • Ms. Marianne de Battisti (Age 66)
    Head of Institutional Relations & Group Communication
  • Mr. Marc le Blanc (Age 45)
    Head of HR
  • Ms. Emmanuelle Baboulin (Age 56)
    Head of the Commercial Property Investment Division













CDMGF Stock - Frequently Asked Questions

Should I buy or sell Icade stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Icade in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CDMGF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDMGF, but not buy additional shares or sell existing shares.
View CDMGF analyst ratings
or view top-rated stocks.

What is Icade's stock price forecast for 2022?

6 Wall Street research analysts have issued 12 month target prices for Icade's shares. Their CDMGF share price forecasts range from $50.00 to $68.50. On average, they predict the company's stock price to reach $62.62 in the next twelve months. This suggests a possible upside of 28.0% from the stock's current price.
View analysts price targets for CDMGF
or view top-rated stocks among Wall Street analysts.

How have CDMGF shares performed in 2022?

Icade's stock was trading at $68.4120 at the beginning of 2022. Since then, CDMGF stock has decreased by 28.5% and is now trading at $48.93.
View the best growth stocks for 2022 here
.

Are investors shorting Icade?

Icade saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 3,900 shares, an increase of 14.7% from the July 15th total of 3,400 shares. Based on an average trading volume of 800 shares, the days-to-cover ratio is presently 4.9 days.
View Icade's Short Interest
.

What is Icade's stock symbol?

Icade trades on the OTCMKTS under the ticker symbol "CDMGF."

How do I buy shares of Icade?

Shares of CDMGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Icade's stock price today?

One share of CDMGF stock can currently be purchased for approximately $48.93.

How many employees does Icade have?

The company employs 1,178 workers across the globe.

How can I contact Icade?

Icade's mailing address is Millénaire 1, Paris, Ile-de-France 75019. The official website for the company is www.icade.fr. The company can be reached via phone at 33 1 41 57 70 00.

This page (OTCMKTS:CDMGF) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.